The global industry was valued at US$ 2.2 Bn in 2022 and is estimated to grow at a CAGR of 4.7% from 2023 to 2031, reaching US$ 3.6 Bn by the end of 2031. The cancer cachexia market is gaining increasing attention as healthcare providers and pharmaceutical companies focus on addressing one of the most severe complications associated with cancer. Cancer cachexia, a multifactorial syndrome...

Cancer cachexia is a complex metabolic syndrome commonly associated with advanced cancer stages, characterized by progressive weight loss, muscle wasting, reduced appetite, and declining physical function. This condition significantly impacts patients’ quality of life, treatment tolerance, and overall survival outcomes. With the growing global burden of cancer and increasing recognition...